NASDAQ · CLRB

Cellectar Biosciences, Inc.

Closing price · Nov 13, 2026 $1.14

Last insider buy price $2.88 Paid by COO Jarrod Longcor on May 7, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 10, 2026

Cash from operationsWorse

−$9.41M

Dec '24Sep '26

vs. −$4.28M a year ago

Share countDiluting

+136.8%

Dec '24Sep '26

10.04M shares vs. 4.24M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13 Funds: as of Jun 30, 2026

account_balance
1 fund bought, 0 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
info
1 real insider sale in 12 months. $733 in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

29 funds report owning CLRB, up from 19

Holdings as of Jun 30, 2026

New14

Added5

Held9

Trimmed1

Sold out4

Last quarter

Who bought and who sold

Apr–Jun 2026

Caligan Partners LP

New

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 12 months. No real trades in the last 6.

Showing 3 real trades. Bigger dot means a bigger trade.

Real trades, newest first

May 7 James Caruso CEO, Director Open-market buy $25K 8,680 sh at $2.88

May 7 Jarrod Longcor COO Open-market buy $25K 8,680 sh at $2.88

Dec 12 John Neis Director Open-market sale $733 198 sh at $3.70 Sold 95% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in CLRB

As of Jun 30, 2026

Fund	Owns	Value	Change
Caligan Partners LP	4.7%	$1.31M	New
Stempoint Capital LP	3.5%	$987K	New
Vanguard Capital Management LLC	3.3%	$910K	+300%
Silverarc Capital Management, LLC	3.2%	$894K	New
Bleichroeder LP	2.9%	$803K	+189%

"Owns" is shares reported divided by shares outstanding.